Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alba Guglielmo

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|September 6, 2021
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future PerspectivesGabriele Roccuzzo, Silvia Giordano, Paolo Fava, et al.
Discover Oncology|November 26, 2025
Chlormethine gel effectiveness as second-line treatment in mycosis fungoides: a single-centre retrospective studyCorrado Zengarini, Alba Guglielmo, Ludovica Vocale, et al.
Frontiers in Immunology|August 27, 2025
Unraveling the role of chemokines in cutaneous T-cell lymphoma: expression levels at different stagesAlba Guglielmo, Corrado Zengarini, Federica Tugnoli, et al.
Cells|October 23, 2021
The Microenvironment's Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic ImplicationsAlessandro Pileri, Alba Guglielmo, Vieri Grandi, et al.
Clinical and Experimental Dermatology|June 9, 2026
Tumor-field predominant bullous pemphigoid in a patient with metastatic melanomaAlessia Caligiure, Endrio Kaja, Alba Guglielmo, et al.
Expert Review of Clinical Immunology|February 19, 2026
Skin toxicities related to Bruton tyrosine kinase inhibitors: an updated reviewStephano Cedirian, Vito Epifani, Gianluca Cafasso, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|October 3, 2024
Daily Patient's Relief From Pruritus and Sleep Disturbance Over One-Month Treatment with Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Multicenter Prospective StudyElena Pezzolo, Maddalena Napolitano, Alessandra Narcisi, et al.
Frontiers in Medicine|August 13, 2021
<i>PTEN</i> Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular PathogenesisGiovanni Innella, Elena Bonora, Iria Neri, et al.
Dermatologic Therapy|August 14, 2020
Cutaneous adverse-events in patients treated with IbrutinibAlessandro Pileri, Alba Guglielmo, Claudio Agostinelli, et al.
Contact Dermatitis|May 22, 2025
The Italian Trend of Contact Allergy to 2-Hydroxyethyl Methacrylate: Is the Current European Legislation Working?Elena Sofia Caroppo, Gabriele Casciola, Katharina Hansel, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|September 6, 2021
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future PerspectivesGabriele Roccuzzo, Silvia Giordano, Paolo Fava, et al.
Discover Oncology|November 26, 2025
Chlormethine gel effectiveness as second-line treatment in mycosis fungoides: a single-centre retrospective studyCorrado Zengarini, Alba Guglielmo, Ludovica Vocale, et al.
Frontiers in Immunology|August 27, 2025
Unraveling the role of chemokines in cutaneous T-cell lymphoma: expression levels at different stagesAlba Guglielmo, Corrado Zengarini, Federica Tugnoli, et al.
Cells|October 23, 2021
The Microenvironment's Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic ImplicationsAlessandro Pileri, Alba Guglielmo, Vieri Grandi, et al.
Clinical and Experimental Dermatology|June 9, 2026
Tumor-field predominant bullous pemphigoid in a patient with metastatic melanomaAlessia Caligiure, Endrio Kaja, Alba Guglielmo, et al.
Expert Review of Clinical Immunology|February 19, 2026
Skin toxicities related to Bruton tyrosine kinase inhibitors: an updated reviewStephano Cedirian, Vito Epifani, Gianluca Cafasso, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|October 3, 2024
Daily Patient's Relief From Pruritus and Sleep Disturbance Over One-Month Treatment with Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Multicenter Prospective StudyElena Pezzolo, Maddalena Napolitano, Alessandra Narcisi, et al.
Frontiers in Medicine|August 13, 2021
<i>PTEN</i> Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular PathogenesisGiovanni Innella, Elena Bonora, Iria Neri, et al.
Dermatologic Therapy|August 14, 2020
Cutaneous adverse-events in patients treated with IbrutinibAlessandro Pileri, Alba Guglielmo, Claudio Agostinelli, et al.
Contact Dermatitis|May 22, 2025
The Italian Trend of Contact Allergy to 2-Hydroxyethyl Methacrylate: Is the Current European Legislation Working?Elena Sofia Caroppo, Gabriele Casciola, Katharina Hansel, et al.
Pageof 7